Back
Ascendis Pharma A/S Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
32
ASND
Ascendis Pharma A/S
Last Price:
120.97
Seasonality Move:
2.88%
Buy
55
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.10
Seasonality Move:
-1.36%
Sell
32
Ascendis Pharma A/S (ASND)
is a Sell
Is Ascendis Pharma A/S a Buy, Sell or Hold?
- The current Ascendis Pharma A/S [ASND] share price is $121.12. The Score for ASND is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Adaptimmune Therapeutics PLC (ADAP)
is a Buy
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.11. The Score for ADAP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- ADAP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ASND Stock Price Chart
What is Ascendis Pharma A/S's stock price today?
-
The Ascendis Pharma A/S share price today is $121.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.47 | Sell |
Relative Strength Index (14 RSI): | 25.2 | Sell |
Chaikin Money Flow: | -344764 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (129.48 - 143) | Sell |
Bollinger Bands (100): | (131.94 - 150.44) | Sell |
ADAP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 44.73 | Sell |
Chaikin Money Flow: | -768979 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.03 - 1.19) | Buy |
Bollinger Bands (100): | (0.89 - 1.47) | Sell |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 128.17 | Sell |
20-day SMA: | 134.8 | Sell |
50-day SMA: | 142.56 | Sell |
200-day SMA: | 119.19 | Buy |
8-day EMA: | 127.19 | Sell |
20-day EMA: | 133.25 | Sell |
50-day EMA: | 138.45 | Sell |
200-day EMA: | 125.58 | Sell |
ADAP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.16 | Sell |
20-day SMA: | 1.14 | Sell |
50-day SMA: | 1.27 | Sell |
200-day SMA: | 0.91 | Buy |
8-day EMA: | 1.16 | Sell |
20-day EMA: | 1.16 | Sell |
50-day EMA: | 1.19 | Sell |
200-day EMA: | 1.09 | Buy |
Ascendis Pharma A/S Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.31 per share, an increase next quarter of $1.21 per share, an increase this year of $3.95 per share, and an increase next year of $5.27 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and an increase next year of $0.14 per share.
Ascendis Pharma A/S Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Adaptimmune Therapeutics PLC Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |